Not a healthcare professional? Visit our Public site

report_adverse_events REPORT ADVERSE EVENT Login Register notification bell

Placeholder

    Contact us REQUEST A REPRESENTATIVE

    Your browser is not supported.

    To view this content, please use one of the following browsers:

    • Microsoft Edge
    • Chrome
    • Safari
    • Home
    • Resources
    • Webinars & Videos
    • Update on The Management of Intraabdominal Candidiasis Case-Based Insights - November 2025

    Update on The Management of Intraabdominal Candidiasis Case-Based Insights - November 2025

    Update on The Management of Intraabdominal Candidiasis Case-Based Insights - November 2025

    Get access to exclusive content and news updates:

    Subscribe Now
    calendar
    time 39:33
    language English
    Job Code: IE-RZF-2500074 | March 2026

    Speakers of Update on The Management of Intraabdominal Candidiasis Case-Based Insights - November 2025

    Speakers

    Watch Professor Ignacio-Martin Loeches and Dr Carolina Garcia-Vidal talk around their experience with Rezafungin and intraabdominal candidiasis. The meeting was chaired by Dr Carolyn Hemsley.
    Prescribing Information UK REZZAYO® (rezafungin)

    Related Videos

    UK-RZF-2600024 March 2026

    Reporting adverse events

    Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.

    Adverse events should also be reported to Napp Pharmaceuticals Limited on 01223 424444 or drugsafetyUKandROI@mundipharma.com.